|
Market Closed -
Hong Kong S.E.
04:08:09 2026-10-23 am EDT
|
5-day change | 1st Jan Change | ||
| 8.345 HKD | -0.12% |
|
-6.02% | -1.01% |
| Oct. 23 | CSPC Pharma's Injection for Rare Autoimmune Disease Gets Regulatory Nod in China | MT |
| Oct. 22 | Pharma sector doubles down on AI to slash costs, timelines | RE |
| Market Cap | 95.27B 12.15B 10.85B 10.02B 9.08B 16.99B 1,153B 17.27B 121B 47.75B 604B 45.59B 44.62B 1,905B | P/E 2026 * |
9.39x | P/E 2027 * | 13.8x |
|---|---|---|---|---|---|
| Enterprise Value | 84.05B 10.72B 9.57B 8.84B 8.01B 14.99B 1,017B 15.24B 106B 42.12B 533B 40.22B 39.36B 1,681B | EV / Sales 2026 * |
2.18x | EV / Sales 2027 * | 2.27x |
| Free-Float |
67.42% | Yield 2026 * |
5.51% | Yield 2027 * | 4.42% |
| Markets | Quality | ||
|---|---|---|---|
Hong Kong S.E.
| 1093 | Delayed | |
Tradegate
| CVG | Real-time | |
|
OTC Markets
| CHJTF | Delayed | |
|
Börse Stuttgart
| CVG | Delayed | |
|
Deutsche Boerse AG
| CVG | Delayed | |
|
Boerse Muenchen
| CVG | Real-time |
| 1 day | -0.12% | ||
| 1 week | -6.02% | ||
| Current month | -17.13% | ||
| 1 month | -10.65% | ||
| 3 months | -2.40% | ||
| 6 months | -7.07% | ||
| Current year | -1.01% |
| 1 week | 8.07 |  | 9.18 |
| 1 month | 8.07 | | 10.16 |
| Current year | 6.53 | | 10.96 |
| 1 year | 6.53 | | 10.96 |
| 3 years | 4.27 | | 11.63 |
| 5 years | 4.27 | | 11.63 |
| 10 years | 3.87 | | 13.93 |
| Manager | Title | Age | Since |
|---|---|---|---|
George Cai
CEO | Chief Executive Officer | 46 | 2025-12-18 |
Qing Jie Wei
COO | Chief Operating Officer | 56 | 2025-12-18 |
Zhi Yong Qu
PRN | Corporate Officer/Principal | 44 | 2024-06-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Dong Chen Cai
CHM | Chairman | 72 | 2011-08-25 |
Zhen Guo Wang
BRD | Director/Board Member | 56 | 2012-01-19 |
Bo Wang
BRD | Director/Board Member | 66 | 2012-12-20 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 6/23/26 | Other | Director | -700,000 | 0.0061% | ||
| 5/29/26 | Other | Chairman | 9,402,000 | 0.0816% | ||
| 5/28/26 | Other | Chairman | 40,000,000 | 0.3471% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.12% | -6.02% | +5.77% | +44.88% | 12.15B | |
| -2.54% | +1.31% | +54.27% | +114.96% | 1,135B | |
| -1.42% | +3.23% | +38.56% | +74.44% | 636B | |
| +0.16% | +0.08% | +25.29% | +95.23% | 505B | |
| -0.31% | +3.09% | +44.14% | +64.80% | 378B | |
| -1.34% | -0.47% | +66.04% | +41.00% | 358B | |
| -0.68% | +2.65% | +22.98% | +50.39% | 295B | |
| -1.20% | +3.04% | +2.33% | +22.86% | 266B | |
| -1.79% | +1.57% | +50.56% | +59.08% | 237B | |
| -0.73% | -0.10% | +29.02% | +99.67% | 193B | |
| Average | -1.00% | +1.35% | +33.90% | +66.73% | 401.65B | |
| Weighted average by Cap. | -1.34% | +2.64% | +40.92% | +79.65% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 38.49B 4.91B 4.38B 4.05B 3.67B 6.86B 466B 6.98B 48.72B 19.29B 244B 18.42B 18.03B 770B | 35.7B 4.55B 4.06B 3.76B 3.4B 6.37B 432B 6.47B 45.19B 17.89B 226B 17.08B 16.72B 714B |
| Net income | 10.15B 1.29B 1.16B 1.07B 967M 1.81B 123B 1.84B 12.84B 5.08B 64.34B 4.85B 4.75B 203B | 7.02B 895M 799M 738M 669M 1.25B 84.97B 1.27B 8.89B 3.52B 44.52B 3.36B 3.29B 140B |
| Net Debt | -11.22B -1.43B -1.28B -1.18B -1.07B -2B -136B -2.03B -14.2B -5.62B -71.17B -5.37B -5.26B -224B | -14.29B -1.82B -1.63B -1.5B -1.36B -2.55B -173B -2.59B -18.09B -7.16B -90.64B -6.84B -6.69B -286B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-23 | HK$8.345 | -0.12% | 91,972,087 |
| 26-10-22 | HK$8.355 | -3.97% | 101,505,293 |
| 26-10-21 | HK$8.700 | -2.47% | 68,012,315 |
| 26-10-20 | HK$8.920 | +0.45% | 47,651,416 |
| 26-10-16 | HK$8.880 | +0.17% | 72,899,598 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 1093 Stock
Select your edition
All financial news and data tailored to specific country editions
